Johnson & Johnson

Page 12 of 18

Portrait of Pascal Soriot, AstraZeneca CEO
Health

Under fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials

By
September 24, 2020
Oxford-Vaccine-Trials-Kaiser-Health-News
Health

Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing

By
August 24, 2020
Johnson & Johnson just invested in a telemedicine startup. Here’s why
Tech

Johnson & Johnson just invested in a telemedicine startup. Here’s why

By
August 14, 2020
Johnson & Johnson antidepressant spray approved for treating those at risk of suicide
Health

Johnson & Johnson antidepressant spray approved for treating those at risk of suicide

By Cynthia Koons and Bloomberg
August 3, 2020
Brainstorm Health 2020-Alex Gorsky
Newsletters

Johnson & Johnson’s CEO on building trust for a coronavirus vaccine

By
July 9, 2020
Brainstorm Health 2020-Alex Gorsky
Newsletters

J&J’s CEO says creating a vaccine is only ‘part of the puzzle’

By Katherine Dunn and Alan Murray
July 9, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health

5 companies to keep an eye on following the world’s largest cancer conference

By
June 3, 2020
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
Newsletters

Big pharma’s big chance

By Katherine Dunn and Alan Murray
April 3, 2020
J&J coronavirus vaccine
Newsletters

Johnson & Johnson CEO on the race to make a coronavirus vaccine

By Katherine Dunn and Alan Murray
March 31, 2020
J&J coronavirus
Newsletters

J&J’s coronavirus vaccine could hit the market by 2021

By
March 30, 2020
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
Health

Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021

By
March 30, 2020
Apple J&J heart study
Newsletters

Apple and Johnson & Johnson team up on heart study

By
February 26, 2020
fortune global forum
Newsletters

The CEO’s Job Is Tougher Than Ever

By Aaron Pressman and Adam Lashinsky
November 18, 2019
What the Sackler Offer and the J&J Opioid Verdict Tell Us About the Next Big Test for Drugmakers—an Ohio Trial in October
Finance

What the Sackler Offer and the J&J Opioid Verdict Tell Us About the Next Big Test for Drugmakers—an Ohio Trial in October

By
August 27, 2019
A judge has ordered the company to pay $572 million in connection with the opioid crisis in Oklahoma
Health

J&J Shares Rise After Lower Than Expected Award for Company’s Part in Opioid Crisis

By Jef Feeley, Riley Griffin and Bloomberg
August 27, 2019

Most Popular